- call +1-201-465-4211
- email sales@mrinsights.biz
Micafungin (trade name Mycamine) is an echinocandin antifungal drug used to treat and prevent invasive fungal infections including candidemia, abscesses and esophageal candidiasis. It inhibits the production of beta-1,3-glucan, an essential component of fungal cell walls. Micafungin is administered intravenously. It received final approval from the U.S. Food and Drug Administration on March 16, 2005, and gained approval in the European Union on April 25, 2008.
Scope of the Report:
In 2013, Japan was the largest consumption place, with a consumption market share nearly 35.40%. In 2017, North America is the largest consumption place with the consumption market share of 28.98%.
Astellas is the leader of the industry, and it holds key technologies and patents, with high-end customers; has been formed in the monopoly position in the industry.
The worldwide market for Micafungin Sodium for Injection is expected to grow at a CAGR of roughly -4.6% over the next five years, will reach 290 million US$ in 2024, from 380 million US$ in 2019, according to a new study.
This report focuses on the Micafungin Sodium for Injection in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Astellas
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
50 mg Single-use Vial
100 mg Single-use Vial
Market Segment by Applications, can be divided into
Candidemia
Respiratory Mycosis
Gastrointestinal Mycosis
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Micafungin Sodium for Injection product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Micafungin Sodium for Injection, with price, sales, revenue and global market share of Micafungin Sodium for Injection in 2017 and 2018.
Chapter 3, the Micafungin Sodium for Injection competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Micafungin Sodium for Injection breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Micafungin Sodium for Injection market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Micafungin Sodium for Injection sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Micafungin Sodium for Injection Introduction
1.2 Market Analysis by Type
1.2.1 50 mg Single-use Vial
1.2.2 100 mg Single-use Vial
1.3 Market Analysis by Applications
1.3.1 Candidemia
1.3.2 Respiratory Mycosis
1.3.3 Gastrointestinal Mycosis
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Astellas
2.1.1 Business Overview
2.1.2 Micafungin Sodium for Injection Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Astellas Micafungin Sodium for Injection Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Micafungin Sodium for Injection Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Micafungin Sodium for Injection Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Micafungin Sodium for Injection Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Micafungin Sodium for Injection Manufacturer Market Share in 2018
3.3.2 Top 6 Micafungin Sodium for Injection Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Micafungin Sodium for Injection Market Analysis by Regions
4.1 Global Micafungin Sodium for Injection Sales, Revenue and Market Share by Regions
4.1.1 Global Micafungin Sodium for Injection Sales and Market Share by Regions (2014-2019)
4.1.2 Global Micafungin Sodium for Injection Revenue and Market Share by Regions (2014-2019)
4.2 North America Micafungin Sodium for Injection Sales and Growth Rate (2014-2019)
4.3 Europe Micafungin Sodium for Injection Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Micafungin Sodium for Injection Sales and Growth Rate (2014-2019)
4.5 South America Micafungin Sodium for Injection Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Micafungin Sodium for Injection Sales and Growth Rate (2014-2019)
5 North America Micafungin Sodium for Injection by Country
5.1 North America Micafungin Sodium for Injection Sales, Revenue and Market Share by Country
5.1.1 North America Micafungin Sodium for Injection Sales and Market Share by Country (2014-2019)
5.1.2 North America Micafungin Sodium for Injection Revenue and Market Share by Country (2014-2019)
5.2 United States Micafungin Sodium for Injection Sales and Growth Rate (2014-2019)
5.3 Canada Micafungin Sodium for Injection Sales and Growth Rate (2014-2019)
5.4 Mexico Micafungin Sodium for Injection Sales and Growth Rate (2014-2019)
6 Europe Micafungin Sodium for Injection by Country
6.1 Europe Micafungin Sodium for Injection Sales, Revenue and Market Share by Country
6.1.1 Europe Micafungin Sodium for Injection Sales and Market Share by Country (2014-2019)
6.1.2 Europe Micafungin Sodium for Injection Revenue and Market Share by Country (2014-2019)
6.2 Germany Micafungin Sodium for Injection Sales and Growth Rate (2014-2019)
6.3 UK Micafungin Sodium for Injection Sales and Growth Rate (2014-2019)
6.4 France Micafungin Sodium for Injection Sales and Growth Rate (2014-2019)
6.5 Russia Micafungin Sodium for Injection Sales and Growth Rate (2014-2019)
6.6 Italy Micafungin Sodium for Injection Sales and Growth Rate (2014-2019)
7 Asia-Pacific Micafungin Sodium for Injection by Country
7.1 Asia-Pacific Micafungin Sodium for Injection Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Micafungin Sodium for Injection Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Micafungin Sodium for Injection Revenue and Market Share by Country (2014-2019)
7.2 China Micafungin Sodium for Injection Sales and Growth Rate (2014-2019)
7.3 Japan Micafungin Sodium for Injection Sales and Growth Rate (2014-2019)
7.4 Korea Micafungin Sodium for Injection Sales and Growth Rate (2014-2019)
7.5 India Micafungin Sodium for Injection Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Micafungin Sodium for Injection Sales and Growth Rate (2014-2019)
8 South America Micafungin Sodium for Injection by Country
8.1 South America Micafungin Sodium for Injection Sales, Revenue and Market Share by Country
8.1.1 South America Micafungin Sodium for Injection Sales and Market Share by Country (2014-2019)
8.1.2 South America Micafungin Sodium for Injection Revenue and Market Share by Country (2014-2019)
8.2 Brazil Micafungin Sodium for Injection Sales and Growth Rate (2014-2019)
8.3 Argentina Micafungin Sodium for Injection Sales and Growth Rate (2014-2019)
8.4 Colombia Micafungin Sodium for Injection Sales and Growth Rate (2014-2019)
9 Middle East and Africa Micafungin Sodium for Injection by Countries
9.1 Middle East and Africa Micafungin Sodium for Injection Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Micafungin Sodium for Injection Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Micafungin Sodium for Injection Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Micafungin Sodium for Injection Sales and Growth Rate (2014-2019)
9.3 Turkey Micafungin Sodium for Injection Sales and Growth Rate (2014-2019)
9.4 Egypt Micafungin Sodium for Injection Sales and Growth Rate (2014-2019)
9.5 Nigeria Micafungin Sodium for Injection Sales and Growth Rate (2014-2019)
9.6 South Africa Micafungin Sodium for Injection Sales and Growth Rate (2014-2019)
10 Global Micafungin Sodium for Injection Market Segment by Type
10.1 Global Micafungin Sodium for Injection Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Micafungin Sodium for Injection Sales and Market Share by Type (2014-2019)
10.1.2 Global Micafungin Sodium for Injection Revenue and Market Share by Type (2014-2019)
10.2 50 mg Single-use Vial Sales Growth and Price
10.2.1 Global 50 mg Single-use Vial Sales Growth (2014-2019)
10.2.2 Global 50 mg Single-use Vial Price (2014-2019)
10.3 100 mg Single-use Vial Sales Growth and Price
10.3.1 Global 100 mg Single-use Vial Sales Growth (2014-2019)
10.3.2 Global 100 mg Single-use Vial Price (2014-2019)
11 Global Micafungin Sodium for Injection Market Segment by Application
11.1 Global Micafungin Sodium for Injection Sales Market Share by Application (2014-2019)
11.2 Candidemia Sales Growth (2014-2019)
11.3 Respiratory Mycosis Sales Growth (2014-2019)
11.4 Gastrointestinal Mycosis Sales Growth (2014-2019)
12 Micafungin Sodium for Injection Market Forecast (2019-2024)
12.1 Global Micafungin Sodium for Injection Sales, Revenue and Growth Rate (2019-2024)
12.2 Micafungin Sodium for Injection Market Forecast by Regions (2019-2024)
12.2.1 North America Micafungin Sodium for Injection Market Forecast (2019-2024)
12.2.2 Europe Micafungin Sodium for Injection Market Forecast (2019-2024)
12.2.3 Asia-Pacific Micafungin Sodium for Injection Market Forecast (2019-2024)
12.2.4 South America Micafungin Sodium for Injection Market Forecast (2019-2024)
12.2.5 Middle East and Africa Micafungin Sodium for Injection Market Forecast (2019-2024)
12.3 Micafungin Sodium for Injection Market Forecast by Type (2019-2024)
12.3.1 Global Micafungin Sodium for Injection Sales Forecast by Type (2019-2024)
12.3.2 Global Micafungin Sodium for Injection Market Share Forecast by Type (2019-2024)
12.4 Micafungin Sodium for Injection Market Forecast by Application (2019-2024)
12.4.1 Global Micafungin Sodium for Injection Sales Forecast by Application (2019-2024)
12.4.2 Global Micafungin Sodium for Injection Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Micafungin Sodium for Injection Picture
Table Product Specifications of Micafungin Sodium for Injection
Figure Global Sales Market Share of Micafungin Sodium for Inj
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
